Cystic fibrosis is the most frequent hereditary and life-threatening multiorgan disease in Western Europe. If both parents are healthy carriers of cystic fibrosis, there is a 25% risk of their child having the disease. EVITA TEST CF analyses the fetus’ DNA for the 50 most frequent pathogenic variants of the cystic fibrosis gene. If none of these variants are present, the risk of having a child with cystic fibrosis is extremely small. EVITA TEST CF is the only test on the market that examines both the genes of the pregnant woman and the fetus. EVITA TEST CF can be performed from week 10 – 14.
Subscribe to our newsletter to get the latest updates on products and new scientific publications on ARCEDI technology
Main office
Tabletvej 1 | DK-7100 Vejle | Denmark
Aarhus office
INCUBA | Palle Juul-Jensens Boulevard 82 |
DK-8200 Aarhus N | Denmark
If you have any questions regarding ARCEDI,
you are welcome to contact us
CVR nr.: 25577922
ARCEDI’s prenatal tests can give you peace of mind concerning your future child. Learn more about EVITA TEST COMPLETE and EVITA TEST GENDER at evitatest.com